LONDON / CHICAGO (Reuters) – It is a dog-eating dog in the world of COVID-19 vaccines. That’s the fear that global health agencies will plan a scheme to buy in bulk and distribute vaccines equitably around the world. They watch with dismay how some wealthier countries have decided to go …
Read More »the first phase 3 trial of a coronavirus vaccine It started this week, with plans to enroll 30,000 volunteers by the time it ends, and more phase 3 trials are likely to start soon. While we all look forward to a safe and effective vaccine as soon as possible, the …
Read More »
MOSCOW (Reuters) – Russia’s first potential COVID-19 vaccine will obtain local regulatory approval in the first half of August and be administered to front-line health workers soon after, a development source close to the matter told Reuters. FILE PHOTO: The Executive President of the Russian Direct Investment Fund, Kirill Dmitriev, …
Read More »
Russia plans to approve the world’s first COVID-19 vaccine in less than two weeks, despite concerns about its safety and efficacy at the breakneck pace destined to beat the rest of the world, according to a report. Russian authorities told CNN they expect the vaccine, created by the Moscow-based Gamaleya …
Read More »
LONDON / PARIS (Reuters) – Britain has signed an agreement for up to 60 million doses of a possible COVID-19 vaccine developed by Sanofi (SASY.PA) and GlaxoSmithKline (GSK.L), he said Wednesday, heats up his fourth deal, like the race to tame the pandemic. FILE PHOTO: Small bottles labeled with “Vaccine” …
Read More »